Диссертация (1139943), страница 22
Текст из файла (страница 22)
97–108.124. Knopman D. S. Current treatement of mild cognitive impairement anAlzheimer’s disesase // Curr. Neurol. Neurosci. Rep. — 2006. — № 6 (5). —С. 365–371.125. Launer L. J., Masaki К., Petrovitch H., Foley D., Havlik R. J. The assotiationbetween midlife blood pressure levels and late-life cognitive function. TheHonolulu-Asia Aging Study // JAMA. — 1995. — № 274 (23). — С. 1846–1851.126.
de Leeuw F.-E., de Groot J. C., Oudkerk M. et al. Hypertension and cerebralwhite matter lesions in a prospective cohort study // Brain. — 2002. — Т. 125.— № 4. — С. 765–772.127. Levine D. A., Langa K. M. Vascular Cognitive Impairment: DiseaseMechanisms and Therapeutic Implication // Neurotherapeutics. — 2011. — №.8. — С. 361–373.128. Leys D., Henon H., Mackowiak–Cordoliani M. A., Pasquier F. Poststrokedementia // Lancet Neurol. — 2005.
— № 4 (11). — С. 752–759.129. Lithell H., Hansson L., Skoog I., Elmfeldt D., Hofman A., SCOPE StudyGroup. The Study on Cognition and Prognosis in the Elderly (SCOPE):principal results of a randomized double-blind intervention trial // J. Hypertens.— 2003. — № 21 (5). — С. 875–886.130. Mahley R. W., Weisgraber K. H., Huang Y. Apolipoprotein E4: a causativefactor and therapeutic target in neuropathology, including Alzheimeer’s disease// Proceedings of the National Academy of Sciences USA. — 2006.
— № 103.С. 5644.131. Manciaa G., Laurentb S., Agabiti-Roseic E. et. Reappraisal of Europeanguidelines of hypertension management: a European Society of HypertensionTask Forse document // J. Hypertension. — 2009. — № 27. — С. 2121–2158.142132. McGuinness B., Todd S., Passmore A., Bullock R. Systematic review: bloodpressure lowering in patients without prior cerebrovascular disease forprevention of cognitive impairment and dementia // J.
Neurol. Neurosurg.Psychiat. — 2008. — № 79. — С. 4–5.133. Morris S., Bradbury A., Mosquera D. Apoptosis in Vascular Disease // Eur. J.Vase. Endovasc. — 2011. — № 22. — С. 389–395.134. Nagaraia D., Jayashree S. Randomised study of the dopamine receptor agonistpiribedil in the treatment of mild cognitive impairment // Am. J. Psychiat.
—2001. — № 158 (9). — С. 1517–1519.135. Nys G. M., van Zandvoort M. J., de Kort P. L. et al. The prognostic value ofdomain–specific cognitive abilities in acute first–ever stroke // Neurol. —2005. — № 64 (5). — С. 821–827.136. Ohmine T., Miwa Y., Yao H., Yuzuriha T., Takashima Y., Uchino A.,Takahashi-Yanaga F., Morimoto S., Maehara Y., Sasaguri T. Associationbetween arterial stiffness and cerebral white matter lesions in communitydwelling elderly subjects // Hypertension research (Jap.). — 2008.
— № 31. —С. 75–81.137. Patyar S., Prakash A., Modi M., Medhi B. Role of vinpocetine incerebrovascular diseases // Pharmacol. Rep. — 2011. — № 63 (3). — С. 618–628.138. Pedelty L., Nyenhuis D. L. Vascular Cognitive Impairment // CurrentTreatment Options in Cardiovascular Medicine. — 2006. — № 8.
— С. 243–250.139. Peila R., White L. R., Masaki K., Petrovitch H., Launer. Reducing the risk ofdementia: efficacy of long-term treatment of hypertension // Stroke. — 2006.— № 37 (5). — С. 1165–1170.140. Perantie D. C., Koller J. M., Weaver P. M., Lugar H. M., Black K. J., White N.H. et al. Prospectively determined impact of type 1 diabetes on brain volumeduring development // Diabetes. — 2011. — № 60 (11).
— С. 3006–3014.143141. Pereira M., Lunet N., Azevedo A., Barros H. Differences in prevalence,awareness, treatment and control of hypertension between developing anddeveloped countries // J. Hypertens. — 2009. — № 27. — С. 963–975.142. Peters R., Beckett N., Forette F. et al. Incident dementia and blood pressurelowering in the older patients with hypertension. A substudy of the SCOPEtrial // Neurology. — 2008.
— № 70. — С. 1858–1866.143. Petersen R. S., Smith G. E., Waring S. C. et al. Mild cognitive impairement:clinical characterization and outcome // Arch. Neurol. — 1999. — № 56. — С.303–308.144. Prince M. J., Bird A. S., Blizard R. A. Is the cognitive function of olderpatients affected by antihypertensive treatment? Results from 54 months of theMedical Research Council's treatment trial of hypertension in older adults //BMJ. — 1996. — № 312.
— С. 801–805.145. Progress Collaborative Group. Effects of blood pressure lowering withperindopril and indapamade therapy on dementia and cognitive decline inpatients with cerebrovascular disease // Arch. Int. Med. — 2003. — № 163. —С. 1069–1075.146.
Redon J., Olsen M. H., Cooper R. S. et al. Stroke mortality trends from 1990 to2006 in 39 countries from Europe and Central Asia: implications for control ofhigh blood pressure // Eur. Heart J. — 2011. — № 32. — С. 1424–1431.147. Roman G. C. Clinical Forms of Vascular Dementia / В кн.: VascularDementia: Cerebrovascular Mechanisms and Clinical Management. Под ред.Paul, Robert H. — Springler., 2005.
— С. 7–21.148. Rosenberg G. A. Inflammation and white matter damage in vascular cognitiveimpairment // Stroke. — 2009. — № 40. — С. 20–23.149. Saxby B. K., Harrington F., Wesnes K. A. et al. Candesartan and cognitivedecline in Hypertension in the Very Elderly Trial cognitive functionassessment (HYVET-COG): a double-blind, placebo controlled trial // LancetNeurol. — 2008. — № 7. — С. 683–689.144150. Schenk C., Wuerz T., Lerner A. J. Small vessel disease and memory loss: whatthe clinician needs to know to preserve patients’ brain health // Curr.
Cardiol.Rep. — 2013. — № 15 (12). — С. 427.151. Scholing W. E. A double-blind study using psychometric tests. Trivastal versusa reference compound // Temp. Medical. — 1982.152. Scholing W. E. Controlled trial of trivasal retard 50 and comparision withtrivasal 20 in the treatment of clinical and mental signs of neurovasculardisease // Scienc. Med. — 1977. — № 4. — С. 4–8.153. Schwartz G. L., Bailey K.
R., Mosley T. et al. Association of ambulatory bloodpressure with ischemic brain injury // Hypertension. — 2007. — № 49 (6). —С. 1228–1234.154. Scuteri A., Brancati A. M., Gianni W. et al. Arterial stiffness is an independentrisk factor for cognitive impairment in the elderly: a pilot study // J.Hypertension. — 2005. — № 23. — С.
1211–1216.155. Semplicini A., Amodio P., Leonetti G. et al. Diagnostic tools for the study ofvascular cognitive dysfunction in hypertension and antihypertensive drugresearch // Pharmacol. Ther. — 2006. — № 109 (1-2). — С. 274–283.156. Shah R. C., Wilson R. S., Bienias J. L.
et al. Relation of blood pressure to riskof incident Alzheimer’s disease and change in global cognitive function inolder persons // Neuroepidemiology. — 2006. — № 26 (1). — С. 30–36.157. Sheline Y. I., Price J. L., Vaishnavi S. N. et al. Regional white matterhyperintensity burden in automated segmentation distinguishes late-lifedepressed subjects from comparison subjects matched for vascular risk factors// Am. J. Psychiatry. — 2008.
— № 165 (4). — С. 524–532.158. Sierra C., Domenech M., Camafort M., Coca A. Hypertension and mildcognitive impairment // Curr. Hypertens. Rep. — 2012. — № 14. — С. 548–555.159. Simoni M., Li L., Paul N. L. et al. Age- and sex-specific rates of leukoaraiosisin TIA and stroke patients: population-based study // Neurology. — 2012.
—№ 79 (12). С. 1215–1222.145160. Simpson J. E., Fernando M. S., Clark L. White matter lesions in an unselectedcohort of the elderly: astrocytic, microglial and and oligodendrocyte precursorcell response // Current Atherosclerosis Reports. — 2013. — № 15 (330). —С. 5.161. Sing–Manoux A., Marmot M. High blood pressure was associated withcognitive function in middle–age in the Whitehall II study // J. Clin. Epidemiol.— 2005. — № 58.
— С. 1308–1315.162. Skoog I., Lernfelt B., Landahl S. et al. 15-year longitudinal study of bloodpressure and dementia // Lancet. — 1996. — № 347 (9009). — С. 11301.163. Skoog I., Lithell H., Hansson L. et al., SCOPE Study Group. Effect of baselinecognitive function and antihypertensive treatment on cognitive andcardiovascular outcomes: Study on COgnition and Prognosis in the Elderly(SCOPE) // Am. J. Hypertens. — 2005. — № 18 (8). — С. 1052–1059.164.
Solfrizzi V., Frisardi V., Capurso C. et al. Dietary fatty acids in dementia andpredementia syndromes: epidemiological evidence and possible underlyingmechanisms // Ageing Res. Rev. — 2010. — № 9. — С. 184–199.165. Stephens S., Kenny R. A., Rowan E. et al. Association between mild vascularcognitive impairment and impaired activities of daily living in older strokesurvivors without dementia // J. Amer. Ger. Soc.
— 2005. — № 53 (1). — С.103–107.166. Sugiyama Т., Lee J. D.,Shimizu H. et.al. Influence of treated blood pressure onprogression of silent brain infarction // J. Hypertans. — 1999. — № 17 (5). —С. 679–684.167. Tabert M. H., Manly J. J., Liu X. Neuropsychological prediction of conversionto Alzheimer disease in patients with mild cognitive impairment // ArchivesGeneral Psychiatry — 2006.
— № 63 (8). — С. 916–924.168. Teodorczuk A., Firbank M., Pantoni L. et al. Relationship between baselinewhite-matter changes and development of late-life depressive symptoms //Psychological Medicine. — 2010. — № 40. — С. 603–610.146169. Tham W., Auchus A. P., Thong M. Progression of cognitive impairment afterstroke: one year results from a longitudinal study of Singaporean strokepatients // J. Neurol. Sci. — 2002. — № 203–204. — С. 49–52.170.
de la Torre J. C. Alzheimer Disease as a Vascular Disorder: NosologicalEvidence // Stroke. — 2002. — № 33 (4). — С. 1152–1162.171. Tzourio C., Dufouil C., Ducimetiere P. et al. Cognitive decline in individualswith high blood pressure: a longitudinal study in the elderly. EVA Group //Neurol. — 1999. — № 53. — С. 1948–1952.172. Vicario A., Martinez C. D., Baretto D., Diaz Casale A., Nicolosi L.Hypertension and cognitive decline: impact on executive function // J. Clin.Hypertens.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
